Thursday 22nd July 2021, 3:00pm
Green Bioactives, a plant bio-technology start-up based at Roslin Innovation Centre, has secured two new international contracts to supply its biochemicals to a US chemical company and a Chinese pharmaceuticals manufacturer.
Green Bioactives opened at the beginning of the pandemic and is gearing up to launch its first consumer product later this year.
After recently receiving regulatory approval, Green Bioactives is also targeting the launch of a memory-enhancing supplement - commonly referred to as nootropics - in the autumn. Made from natural plant molecules, it will be the only clinically-trialled product of its kind.
“Winning these two contracts is validation of the technology we have been developing and our products’ relevance to a variety of international markets. The regulatory approval of our consumer nootropics offering is another highly positive piece of news - when it launches later this year the product will act as another important revenue stream for us as we diversify the business. We expect it to be available through a number of well-known retailers, and are in talks to make that happen as we raise more business and make more connections.”
The company has been supported in its development by the Industrial Biotechnology Innovation Centre (IBioIC).
Green Bioactives used the innovation centre’s Bioprocessing Scale Up Centres to increase the production volume of its cultured plant cells, helping to scale production from 50 millilitre laboratory flasks to 20 litre commercial containers.
“Biotechnology companies can often face challenge around scaling their products, with performance changing as you increase production volumes and, with that, the need to use new and larger pieces of equipment. Our facilities are about giving small companies and start-ups access to what they need in the early stages of their development, when how they deploy their capital is incredibly important. There are a lot of exciting Scottish biotechnology companies working with natural materials that have global potential – we look forward to seeing how Green Bioactives develops and continuing our support for the business.”
View original article as published in Business Insider